[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review

September 2021 | 27 pages | ID: S6679344F8EEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Sunovion Pharmaceuticals Inc (Sunovion), a subsidiary of Sumitomo Dainippon Pharma Co Ltd, is a research-based pharmaceutical company. It discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its major products include eslicarbazepine acetate tablets, lurasidone HCl tablets, eszopiclone tablets, glycopyrrolate inhalation solution and levalbuterol tartrate inhalation aerosol. The company’s product candidates are intended for the treatment of schizophrenia, neuropathic pain, bipolar depression, treatment resistant depression, agitation in Alzheimer's disease and Parkinson's disease, among others. It has partnership with various pharmaceutical companies such as Psychogenics and others. Sunovion is headquartered in Marlborough, Massachusetts, the US.

Sunovion Pharmaceuticals Inc Key Recent Developments

Oct 26,2020: Sunovion marks 10 years of addressing serious medical conditions that impact the lives of millions worldwide

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Sunovion Pharmaceuticals Inc - Key Facts
Sunovion Pharmaceuticals Inc - Key Employees
Sunovion Pharmaceuticals Inc - Key Employee Biographies
Sunovion Pharmaceuticals Inc - Major Products and Services
Sunovion Pharmaceuticals Inc - History
Sunovion Pharmaceuticals Inc - Company Statement
Sunovion Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sunovion Pharmaceuticals Inc - Business Description
Sunovion Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Sunovion Pharmaceuticals Inc - Strengths
Sunovion Pharmaceuticals Inc - Weaknesses
Sunovion Pharmaceuticals Inc - Opportunities
Sunovion Pharmaceuticals Inc - Threats
Sunovion Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunovion Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 26, 2020: Sunovion marks 10 years of addressing serious medical conditions that impact the lives of millions worldwide

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sunovion Pharmaceuticals Inc, Key Facts
Sunovion Pharmaceuticals Inc, Key Employees
Sunovion Pharmaceuticals Inc, Key Employee Biographies
Sunovion Pharmaceuticals Inc, Major Products and Services
Sunovion Pharmaceuticals Inc, History
Sunovion Pharmaceuticals Inc, Other Locations
Sunovion Pharmaceuticals Inc, Subsidiaries
Sunovion Pharmaceuticals Inc, Key Competitors
Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunovion Pharmaceuticals Inc, Recent Deals Summary

LIST OF FIGURES

Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications